TARDIVE DYSKINESIA
Clinical trials for TARDIVE DYSKINESIA explained in plain language.
Never miss a new study
Get alerted when new TARDIVE DYSKINESIA trials appear
Sign up with your email to follow new studies for TARDIVE DYSKINESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for uncontrollable movements
Disease control Not yet recruitingThis study is testing whether an experimental drug called NBI-1065890 can reduce involuntary movements in adults with tardive dyskinesia. About 100 participants with moderate to severe symptoms will receive either the drug or a placebo for 8 weeks. Researchers will measure change…
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 02, 2026 01:41 UTC
-
New hope for treating debilitating movements in overlooked patient group
Disease control Not yet recruitingThis study aims to see if a medication called deutetrabenazine can safely and effectively reduce the involuntary movements of tardive dyskinesia in adults with intellectual and developmental disabilities. It will involve 25 participants who will take the medication for 24 weeks. …
Matched conditions: TARDIVE DYSKINESIA
Phase: PHASE4 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC